Jing You Pharmaceuticals (00858.HK) issues profit warning, expecting a loss of at least HK$950 million for the year, a turn from profit to loss compared to the same period last year.

Wisdom Financial News App reported that Jiangyou Pharmaceutical (00858.HK) issued an announcement, expecting a loss of at least HK$950 million for the year ending March 31, 2026, compared to a profit for the year ending March 31, 2025. The expected change from profit to loss is mainly due to several non-cash items, including: (i) unrealized losses of approximately HK$800 million to HK$850 million on investments in convertible bonds issued by the Star Chain Group Limited (trading of shares suspended on the Stock Exchange of Hong Kong from May 6, 2026), which last year recorded gains from fair value changes on the same project; and (ii) impairment provisions of approximately HK$140 million on the equity of an associated company and loans receivable from that associated company. The operating performance of the Group's business segments remained stable for the year ending March 31, 2026.